Table 2.

Intention to treat main and sensitivity analysis, and subgroup analysis at the 3-month follow-up consultation

	Intervention group % (N/n)	Control group % (N/n)	P value
Primary outcome
Main analysis	61.7% (21/34)	33.3% (13/39)	0.015*‡
Sensitivity analysis
‘Best case scenario’	71.1% (32/45)	29.5% (13/44)	<0.001†‡
‘Worst case scenario’	46.7% (21/45)	40.9% (18/44)	0.584‡
Subgroup analysis
No of chronic diseases
1	77.7% (7/9)	50.0% (4/8)	0.335§
2	70.0% (7/10)	33.3% (3/9)	0.179§
>2	46.7% (7/15)	27.3% (6/22)	0.225‡
No of prescribed drugs
<5	64.3% (9/14)	60.0% (9/15)	0.812‡
≥5	60.0% (12/20)	16.7% (4/24)	0.005*§
Social level
1	37.5% (3/8)	37.5% (6/16)	1§
2	70.0% (7/10)	33.3% (2/6)	0.302§
3	68.8% (11/16)	29.4% (5/17)	0.024*‡
Age (years)
<60	66.7% (10/15)	50.0% (7/14)	0.362‡
≥60	57.9% (11/19)	26.1% (6/23)	0.037*‡
Study disease
Hypertension	62.5% (15/24)	38.5% (10/26)	0.089‡
Type 2 diabetes	33.3% (3/9)	10.0% (1/10)	0.303§
Hypercholesterolaemia	80.0% (4/5)	37.5% (3/8)	0.266§

Data are expressed as percentage of patients reaching their therapeutic goals.

*p<0.05.

†p<0.001.

‡χ² test.

§Fisher test.

N, number reaching therapeutic goal.